jovan vitanovski/Shutterstock

We're in the middle of a gold rush in the cancer-drug industry

In the past five years, 70 new cancer treatments have been approved for more than 20 types of tumors.

That surge in treatments is coming with a high cost. In 2015, global spending on cancer treatments hit $107 billion — up 11.5% from 2014, according to a report released Thursday by the IMS Institute for Healthcare Informatics. Those costs are expected to hit $150 billion by 2020.

The $107 billion is based on what the manufacturers of cancer drugs are making when they sell to health-insurance companies, pharmacy benefits managers, and others. Read more...

businessinsider.com